Our Mission Is To Accelerate The Development Of Innovative Discoveries Into Life-Changing Biological Products And Expand Global Access Of Medicines To Patients In Need.
The following data covers Scope 1 and 2 GHG emissions, water, and waste for the KBI Biopharma sites listed below. This data is reported for fiscal year 2021 covering April 1, 2021 through March 31, 2022. Not all sites reported data due to leased facilities with data access issues. We are working to resolve the issue going forward.